期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 73, 期 24, 页码 E285-U87出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.11.003
关键词
ACC/AHA Clinical Practice Guidelines; Guidelines; biomarkers; coronary artery calcium score; pharmacological; cardiovascular disease; cholesterol; LDL-cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction discussion; risk treatment discussion; secondary prevention; ezetimibe; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors